Actively Recruiting
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
Led by Zealand University Hospital · Updated on 2024-01-30
120
Participants Needed
1
Research Sites
460 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.
CONDITIONS
Official Title
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have been diagnosed with kidney cancer.
You will not qualify if you...
- Patients without signs of malignancy at final histology report.
- Incapacitated patients.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zealand University Hospital
Roskilde, Denmark, 4000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here